New Weight Management Program Q&A
US$ 27.89
glp-1 cardiovascular outcomes 2025 news studies add to growing body of evidence demonstrating significant benefit on APhA 2025: GLP-1 Receptor Agonists
Description
A.EdwardsC
They are particularly concerned with the side effects from GLP-1 medications, as well as long-term potential implications
2025, e70103, Rentzeperi, Elpiniki, et al
Incretin-based therapies touch many of those same systems
